- Ascorbic acid
- Ascorbic acid 2-O-glucoside
- Ascorbic acid stearate
- Ascorbic acid, 6-deoxy-
- 364334-94-14-(2,4-DIMETHYL-1,3-THIAZOL-5-YL)PYRIMIDIN-2-AMINE
- 364360-78-1Benzenamine,2-(bromomethyl)-
- 36436-65-4Ethanone,1-(2-hydroxy-4,5-dimethylphenyl)-
- 36437-19-1Propanedial, 2-chloro-
- 36437-37-3Phenol,2-(2H-benzotriazol-2-yl)-4-(1,1-dimethylethyl)-6-(1-methylpropyl)-
- 364385-74-0Ethyl 4-chloro-6-methoxy quinazoline-2-carboxylate
- 3644-12-02-Propenamide,N-(methoxymethyl)-2-methyl-
- 36441-41-5D-Streptamine, O-a-D-mannopyranosyl-(1®4)-O-2,6-diamino-2,6-dideoxy-b-L-idopyranosyl-(1®3)-O-b-D-ribofuranosyl-(1®5)-O-[2-amino-2,3-dideoxy-a-D-ribo-hexopyranosyl-(1®4)]-2-deoxy-
- 3644-18-61-Piperazineethanamine,N,N-dimethyl-
- 36443-68-2Benzenepropanoic acid,3-(1,1-dimethylethyl)-4-hydroxy-5-methyl-,1,1'-[1,2-ethanediylbis(oxy-2,1-ethanediyl)] ester
Hot Products
- 364360-78-12-(bromomethyl)-Benzenamine
- 36441-34-69,10-Dihydro-1,4-dihydroxy-6,7-dimethoxy-3-methyl-9,10-dioxo-2-anthracenecarboxylic acid
- 36445-84-82-Propenoic acid, 2-hydroxy-, monosodium salt, homopolymer
- 36451-09-92-Diazo-1-naphthol-4-sulfonyl chloride
- 364-53-43,4-DINITROFLUOROBENZENE
- 36484-54-5Phenol, 4,4-(1-methylethylidene)bis-, polymer with (chloromethyl)oxirane and methyloxirane
- 3652-92-41,3-Dimethyl-1,3-dihydro-2-phenyl-2H-benzimidazole
- 36530-06-0BORON SUBPHTHALOCYANINE CHLORIDE
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
|
Basic Information |
|
Post buying leads |
|
Suppliers |
| Name |
Ascorbic acid |
EINECS | N/A |
| CAS No. | 36431-82-0 | Density | g/cm3 |
| PSA | 130.77000 | LogP | 3.13390 |
| Solubility | N/A | Melting Point |
N/A |
| Formula | C32H42N2O7 | Boiling Point | 550.8°Cat760mmHg |
| Molecular Weight | 0 | Flash Point | 224.7°C |
| Transport Information | N/A | Appearance | N/A |
| Safety | Risk Codes | N/A | |
| Molecular Structure |
|
Hazard Symbols | N/A |
| Synonyms |
ASCORBIC ACID |
Ascorbic acid Chemical Properties
Molecular Structure:
Molecular Formula: C32H42N2O7
Molecular Weight: 566.6851
IUPAC Name: (5R)-5-[(1S)-1,2-Dihydroxyethyl]-3,4-dihydroxy-2(5H)-furanon
Synonyms of Ascorbic acid (CAS NO.36431-82-0): (5R)-5-[(1S)-1,2-Dihydroxyethyl]-3,4-dihydroxy-2(5H)-furanone ; (5R)-5-[(1S)-1,2-Dihydroxyethyl]-3,4-dihydroxy-2(5H)-furanone (non-preferred name) ; Calscorbate
Stability: Stable. May be weakly light or air sensitive. Incompatible with oxidizing agents,alkalies, iron, copper
Appearance: white to light yellow crystals or powder
Index of Refraction: 1.711
Density: 1.954 g/ml
Flash Point: 238.2 °C
Boiling Point: 552.7 °C
Melting Point: 191 °C
Classification Code: Drug / Therapeutic Agent
Ascorbic acid Uses
Ascorbic acid (CAS NO.36431-82-0) is used in organic synthesis, drug manufacturing.
Ascorbic acid Toxicity Data With Reference
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| man | TDLo | intravenous | 2300mg/kg/2D (2300mg/kg) | BLOOD: OXIDANT RELATED (GPD DEFICIENT) ANEMIA | Annals of Internal Medicine. Vol. 82, Pg. 810, 1975. |
| mouse | LD50 | intraperitoneal | 643mg/kg (643mg/kg) | Progress in Mutation Research. Vol. 1, Pg. 682, 1981. | |
| mouse | LD50 | intravenous | 518mg/kg (518mg/kg) | Research Progress in Organic-Biological and Medicinal Chemistry. Vol. 2, Pg. 269, 1970. | |
| mouse | LD50 | oral | 3367mg/kg (3367mg/kg) | National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. Vol. JAN1986, | |
| rat | LD50 | intravenous | > 4gm/kg (4000mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | Oyo Yakuri. Pharmacometrics. Vol. 12, Pg. 131, 1976. |
| rat | LD50 | oral | 11900mg/kg (11900mg/kg) | SENSE ORGANS AND SPECIAL SENSES: LACRIMATION: EYE BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" | Oyo Yakuri. Pharmacometrics. Vol. 12, Pg. 131, 1976. |
| rat | LD50 | subcutaneous | > 10gm/kg (10000mg/kg) | Oyo Yakuri. Pharmacometrics. Vol. 12, Pg. 131, 1976. | |
| women | LDLo | intravenous | 900mg/kg (900mg/kg) | KIDNEY, URETER, AND BLADDER: "CHANGES IN TUBULES (INCLUDING ACUTE RENAL FAILURE, ACUTE TUBULAR NECROSIS)" | Archives of Internal Medicine. Vol. 145, Pg. 950, 1985. |
What can I do for you?
Get Best Price
